Topical calcitriol restores the impairment of epidermal permeability and antimicrobial barriers induced by corticosteroids

British Journal of Dermatology

Volumn 162, Issue 6, 2010, Pages 1251-1260

  Hong, S P ^a   Oh, Y ^b   Jung, M ^b   Lee, S ^b   Jeon, H ^b   Cho, M Y ^b   Lee, S H ^c   Choi, E H ^b  

^a Konyang University College of Medicine   (South Korea)

^b Yonsei University Wonju   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

Antimicrobial peptide; Calcitriol; Corticosteroids; Epidermal permeability barrier; Vitamin D3

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; CALCITRIOL; CERAMIDE; CHOLESTEROL; CLOBETASOL PROPIONATE; CORTICOSTEROID; DERMOVATE OINTMENT; FATTY ACID SYNTHASE; OXYGENASE; SERINE PALMITOYLTRANSFERASE; UNCLASSIFIED DRUG; VITAMIN D;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; ELECTRON MICROSCOPY; EPIDERMIS; FEMALE; IMMUNOHISTOCHEMISTRY; LAMELLAR BODY; LIPOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN PERMEABILITY; STRATUM CORNEUM; UPREGULATION; WESTERN BLOTTING;

ADMINISTRATION, TOPICAL; ANIMALS; BLOTTING, WESTERN; CALCITRIOL; CALCIUM CHANNEL AGONISTS; CLOBETASOL; DISEASE MODELS, ANIMAL; ENZYMES; EPIDERMIS; FEMALE; GLUCOCORTICOIDS; IMMUNOHISTOCHEMISTRY; MICE; MICE, HAIRLESS; MICROSCOPY, ELECTRON; OXAZINES; PERMEABILITY; POLYMERASE CHAIN REACTION; SKIN ABSORPTION; UP-REGULATION;

EID: 77952694761     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09760.x     Document Type: Article

References (33)

1. Lehmann B. Role of the vitamin D3 pathway in healthy and diseased skin - facts, contradictions and hypotheses. Exp Dermatol 2009 18 : 97 108.
2. Bikle DD, Chang S, Crumrine D et al. 25 Hydroxyvitamin D 1 alpha-hydroxylase is required for optimal epidermal differentiation and permeability barrier homeostasis. J Invest Dermatol 2004 122 : 984 992.
3. Schauber J, Gallo RL. The vitamin D pathway: A new target for control of the skin's immune response? Exp Dermatol 2008 17 : 633 639.
4. Sheu HM, Lee JY, Chai CY et al. Depletion of stratum corneum intercellular lipid lamellae and barrier function abnormalities after long-term topical corticosteroids. Br J Dermatol 1997 136 : 884 890.
5. Kao JS, Fluhr JW, Man MQ et al. Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities. J Invest Dermatol 2003 120 : 456 464.
6. Aberg KM, Radek KA, Choi EH et al. Psychological stress downregulates epidermal antimicrobial peptide expression and increases severity of cutaneous infections in mice. J Clin Invest 2007 117 : 3339 3349.
7. von Brenken S, Jensen JM, Fartasch M et al. Topical vitamin D3 derivatives impair the epidermal permeability barrier in normal mouse skin. Dermatology 1997 194 : 151 156.
8. Effendy I, Kwangsukstith C, Chiappe M et al. Effects of calcipotriol on stratum corneum barrier function, hydration and cell renewal in humans. Br J Dermatol 1996 135 : 545 549.
9. Queille-Roussel C, Duteil L, Parneix-Spake A et al. The safety of calcitriol 3 microg/g ointment. Evaluation of cutaneous contact sensitization, cumulative irritancy, photoallergic contact sensitization and phototoxicity. Eur J Dermatol 2001 11 : 219 224.
10. Rizova E, Corroller M. Topical calcitriol - studies on local tolerance and systemic safety. Br J Dermatol 2001 144 (Suppl. 58 3 10.
11. Oda Y, Uchida Y, Moradian S et al. Vitamin D receptor and coactivators SRC2 and 3 regulate epidermis-specific sphingolipid production and permeability barrier formation. J Invest Dermatol 2009 129 : 1367 1378.
12. Hong SP, Kim MJ, Jung MY et al. Biopositive effects of low-dose UVB on epidermis: coordinate upregulation of antimicrobial peptides and permeability barrier reinforcement. J Invest Dermatol 2008 128 : 2880 2887.
13. Elias PM, Choi EH. Interactions among stratum corneum defensive functions. Exp Dermatol 2005 14 : 719 726.
14. Aberg KM, Man MQ, Gallo RL et al. Co-regulation and interdependence of the mammalian epidermal permeability and antimicrobial barriers. J Invest Dermatol 2008 128 : 917 925.
15. Greenspan P, Gutman RL. Detection by Nile red of agarose gel electrophoresed native and modified low density lipoprotein. Electrophoresis 1993 14 : 65 8.
16. Menon GK, Feingold KR, Elias PM. Lamellar body secretory response to barrier disruption. J Invest Dermatol 1992 98 : 279 289.
17. Choi EH, Brown BE, Crumrine D et al. Mechanisms by which psychologic stress alters cutaneous permeability barrier homeostasis and stratum corneum integrity. J Invest Dermatol 2005 124 : 587 595.
18. Wood LC, Feingold KR, Sequeira-Martin SM et al. Barrier function coordinately regulates epidermal IL-1 and IL-1 receptor antagonist mRNA levels. Exp Dermatol 1994 3 : 56 60.
19. Oren A, Ganz T, Liu L et al. In human epidermis, beta-defensin 2 is packaged in lamellar bodies. Exp Mol Pathol 2003 74 : 180 182.
20. Braff MH, Di Nardo A, Gallo RL. Keratinocytes store the antimicrobial peptide cathelicidin in lamellar bodies. J Invest Dermatol 2005 124 : 394 400.
21. Wang TT, Nestel FP, Bourdeau V et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 2004 173 : 2909 2912.
22. Stahle M, Mallbris L, Wei T et al. Vitamin D treatment upregulates the antimicrobial protein hCAP18/LL-37 in atopic dermatitis. J Invest Dermatol 2008 128 : (abstr. 53).
23. Weber G, Heilborn JD, Chamorro Jimenez CI et al. Vitamin D induces the antimicrobial protein hCAP18 in human skin. J Invest Dermatol 2005 124 : 1080 1082.
24. Gombart AF, Borregaard N, Koeffler HP. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J 2005 19 : 1067 1077.
25. Lutzow-Holm C, De Angelis P, Grosvik H et al. 1,25-Dihydroxyvitamin D3 and the vitamin D analogue KH1060 induce hyperproliferation in normal mouse epidermis. A BrdUrd/DNA flow cytometric study. Exp Dermatol 1993 2 : 113 120.
26. Vissers WH, van Vlijmen I, van Erp PE et al. Topical treatment of mild to moderate plaque psoriasis with 0·3% tacrolimus gel and 0·5% tacrolimus cream: The effect on SUM score, epidermal proliferation, keratinization, T-cell subsets and HLA-DR expression. Br J Dermatol 2008 158 : 705 712.
27. Bos JD, Meinardi MM. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol 2000 9 : 165 169.
28. Ortonne JP, Humbert P, Nicolas JF et al. Intra-individual comparison of the cutaneous safety and efficacy of calcitriol 3 microg g(-1) ointment and calcipotriol 50 microg g(-1) ointment on chronic plaque psoriasis localized in facial, hairline, retroauricular or flexural areas. Br J Dermatol 2003 148 : 326 333.
29. Solvsten H, Svendsen ML, Fogh K et al. Upregulation of vitamin D receptor levels by 1,25(OH)2 vitamin D3 in cultured human keratinocytes. Arch Dermatol Res 1997 289 : 367 372.
30. Lai Y, Gallo RL. AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol 2009 30 : 131 141.
31. Peric M, Koglin S, Dombrowski Y et al. Vitamin D analogs differentially control antimicrobial peptide/'alarmin' expression in psoriasis. PLoS ONE 2009 4 : e6340.
32. Sidbury R, Sullivan AF, Thadhani RI et al. Randomized controlled trial of vitamin D supplementation for winter-related atopic dermatitis in Boston: A pilot study. Br J Dermatol 2008 159 : 245 247.
33. Hata TR, Kotol P, Jackson M et al. Administration of oral vitamin D induces cathelicidin production in atopic individuals. J Allergy Clin Immunol 2008 122 : 829 831.